Literature DB >> 31971849

Clinically Significant Anxiety in Children with Autism Spectrum Disorder and Varied Intellectual Functioning.

Connor M Kerns1, Breanna Winder-Patel2, Ana Maria Iosif3,4, Christine Wu Nordahl2,4, Brianna Heath2,4, Marjorie Solomon2,4, David G Amaral2,4.   

Abstract

Objective: To evaluate how distinct presentations of anxiety symptoms and intellectual impairment influence the measurement and estimated rate of clinically significant anxiety in autism spectrum disorder (ASD).Method: The sample included 75 children (ages 9-13 years) with ASD and varied IQ and 52 typically developing (TD) controls and parents. Parents completed anxiety symptom scales and a diagnostic interview, designed to (1) differentiate anxiety and ASD and (2) examine DSM-specified and unspecified ("distinct") anxiety presentations in each child, including fears of change, special interests, idiosyncratic stimuli and social confusion rather than evaluation. Children completed standard intellectual and ASD diagnostic assessments.
Results: 69% of those with ASD had clinically-significant anxiety, including 21% DSM-specified anxiety disorders, 17% distinct anxiety, and 31% both. Only 8% of TD children had clinically-significant anxiety, all DSM-specified. DSM-specified anxiety disorders in children with ASD and intellectual impairment (IQ<70) were predominantly specific phobias. DSM-specified anxiety other than specific phobia was significantly less common in children with, versus without, intellectual impairment; this was not the case for distinct anxiety. The sensitivities of anxiety scales were moderate to poor, particularly in cases with intellectual impairment.Conclusions: ASD is associated with more frequent and varied presentations of clinical anxiety, which may align with and differ from the specified anxiety disorders of the DSM. Standard parent report anxiety scales have reduced sensitivity to detect clinical anxiety in ASD, particularly in children with intellectual impairment.

Entities:  

Mesh:

Year:  2020        PMID: 31971849      PMCID: PMC9372909          DOI: 10.1080/15374416.2019.1703712

Source DB:  PubMed          Journal:  J Clin Child Adolesc Psychol        ISSN: 1537-4416


  52 in total

1.  Anxiety and quality of life: clinically anxious children with and without autism spectrum disorders compared.

Authors:  Francisca J A van Steensel; Susan M Bögels; Carmen D Dirksen
Journal:  J Clin Child Adolesc Psychol       Date:  2012-07-09

Review 2.  Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V.

Authors:  Katja Beesdo; Susanne Knappe; Daniel S Pine
Journal:  Psychiatr Clin North Am       Date:  2009-09

3.  Psychometric Properties of the SCARED in Youth with Autism Spectrum Disorder.

Authors:  Jessica A Stern; Milind S Gadgil; Audrey Blakeley-Smith; Judy A Reaven; Susan L Hepburn
Journal:  Res Autism Spectr Disord       Date:  2014-09-01

4.  Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study.

Authors:  B Birmaher; D A Brent; L Chiappetta; J Bridge; S Monga; M Baugher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-10       Impact factor: 8.829

5.  Informant discrepancies in the assessment of childhood psychopathology: a critical review, theoretical framework, and recommendations for further study.

Authors:  Andres De Los Reyes; Alan E Kazdin
Journal:  Psychol Bull       Date:  2005-07       Impact factor: 17.737

6.  Comorbid anxiety symptoms in children with pervasive developmental disorders.

Authors:  P Muris; P Steerneman; H Merckelbach; I Holdrinet; C Meesters
Journal:  J Anxiety Disord       Date:  1998 Jul-Aug

7.  Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.

Authors:  C Lord; M Rutter; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1994-10

8.  Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.

Authors:  Emily Simonoff; Andrew Pickles; Tony Charman; Susie Chandler; Tom Loucas; Gillian Baird
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-08       Impact factor: 8.829

9.  Multiple informant agreement on the anxiety disorders interview schedule in youth with autism spectrum disorders.

Authors:  Eric A Storch; Jill Ehrenreich May; Jeffrey J Wood; Anna M Jones; Alessandro S De Nadai; Adam B Lewin; Elysse B Arnold; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-08-02       Impact factor: 2.576

10.  Intolerance of uncertainty as a framework for understanding anxiety in children and adolescents with autism spectrum disorders.

Authors:  Christina Boulter; Mark Freeston; Mikle South; Jacqui Rodgers
Journal:  J Autism Dev Disord       Date:  2014-06
View more
  11 in total

1.  Often Undiagnosed but Treatable: Case Vignettes and Clinical Considerations for Assessing Anxiety Disorders in Youth with Autism Spectrum Disorder and Intellectual Disability.

Authors:  Breanna Winder-Patel; Megan E Tudor; Connor M Kerns; Konnor Davis; Christine Wu Nordahl; David G Amaral; Marjorie Solomon
Journal:  Evid Based Pract Child Adolesc Ment Health       Date:  2021-10-12

2.  Social functioning and the presentation of anxiety in children on the autism spectrum: A multimethod, multiinformant analysis.

Authors:  Michelle C Hunsche; Matti Cervin; Eric A Storch; Philip C Kendall; Jeffrey J Wood; Connor M Kerns
Journal:  J Psychopathol Clin Sci       Date:  2022-02

3.  A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder.

Authors:  Christopher J McDougle; Robyn P Thom; Caitlin T Ravichandran; Michelle L Palumbo; Laura C Politte; Jennifer E Mullett; Christopher J Keary; Craig A Erickson; Kimberly A Stigler; Lauren Mathieu-Frasier; David J Posey
Journal:  Neuropsychopharmacology       Date:  2022-03-03       Impact factor: 8.294

4.  Examining Associations Between Amygdala Volumes and Anxiety Symptoms in Autism Spectrum Disorder.

Authors:  Heather A Yarger; Christine Wu Nordahl; Elizabeth Redcay
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-10-21

5.  Trajectories of co-occurring psychopathology symptoms in autism from late childhood to adulthood.

Authors:  James B McCauley; Rebecca Elias; Catherine Lord
Journal:  Dev Psychopathol       Date:  2020-10

6.  Fear Potentiated Startle in Children With Autism Spectrum Disorder: Association With Anxiety Symptoms and Amygdala Volume.

Authors:  David Hessl; Lauren Libero; Andrea Schneider; Connor Kerns; Breanna Winder-Patel; Brianna Heath; Joshua Lee; Cory Coleman; Natasha Sharma; Marjorie Solomon; Christine Wu Nordahl; David G Amaral
Journal:  Autism Res       Date:  2020-12-29       Impact factor: 5.216

7.  Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study.

Authors:  Elise Ng-Cordell; Anna Kolesnik-Taylor; Sinéad O'Brien; Duncan Astle; Gaia Scerif; Kate Baker
Journal:  J Autism Dev Disord       Date:  2022-05-10

8.  Anxiety and intellectual functioning in autistic children: A systematic review and meta-analysis.

Authors:  Jessica E Mingins; Joanne Tarver; Jane Waite; Chris Jones; Andrew Dr Surtees
Journal:  Autism       Date:  2020-11-16

9.  Accommodation of Anxiety in Youth with Autism Spectrum Disorder: Results from the TAASD Study.

Authors:  Hannah E Frank; Elana R Kagan; Eric A Storch; Jeffrey J Wood; Connor M Kerns; Adam B Lewin; Brent J Small; Philip C Kendall
Journal:  J Clin Child Adolesc Psychol       Date:  2020-06-08

Review 10.  The Autism Phenome Project: Toward Identifying Clinically Meaningful Subgroups of Autism.

Authors:  Christine Wu Nordahl; Derek Sayre Andrews; Patrick Dwyer; Einat Waizbard-Bartov; Bibiana Restrepo; Joshua K Lee; Brianna Heath; Clifford Saron; Susan M Rivera; Marjorie Solomon; Paul Ashwood; David G Amaral
Journal:  Front Neurosci       Date:  2022-01-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.